ew treatment for long sight by tissue additio
- Conditions
- Health Condition 1: null- healthy individuals with unilateral hypermetropia with amblyopia
- Registration Number
- CTRI/2014/04/004536
- Lead Sponsor
- ethradhama Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 10
ï??HYPERMETROPIA ( > 3D SPHERICAL EQUIVALENT) WITH AMBLYOPIA
ï?? APHAKIA
ï??AGE ABOVE 21 YEARS AND LESS THAN 65 YEARS.
ï??SOFT CONTACT LENS DISCONTINUED FOR MINIMUM 1 WEEK AND RIGID GAS PERMEABLE CONTACT LENS DISCONTINUED FOR MINIMUM 3 WEEKS
ï??ABILITY TO UNDERSTAND AND WILLINGNESS TO SIGN INFORMED CONSENT
ï??WILLINGNESS TO PARTICIPATE IN FOLLOW UP VISITS
•EVIDENCE OF OCULAR DISEASES LIKE SEVERE MEIBOMIAN GLAND DISEASES, HERPETIC KERATITIS, UVIETIS, GLAUCOMA.
•VISUALLY SIGNIFICANT CATARACT, RETINAL DISEASES LIKE RETINAL DYSTROPHIES OR DIABETIC RETINOPATHY.
•CYLINDRICAL POWER >1D.
•ANY PATHOLOGIES OF CORNEA LIKE CORNEAL DYSTROPHIES , KERATOCONUS,ANY H/O CORNEAL TRAUMA OR SURGERY WITHIN FLAP ZONE
•DRY EYE STATUS-SCHIRMERâ??S 2 TEST VALUE LESS THAN 10 MM
•LONG TERM OCULAR MEDICATION LIKE Î? BLOCKERS.
•TAKING ANY SYSTEMIC MEDICATION LIKELY TO AFFECT WOUND HEALING LIKE CORTICOSTEROIDS OR ANTIMETABOLITES.
•H/O IMMUNOCOMPROMISED STATE OR PREGNANCY OR NURSING MOTHERS .
•PATIENTS WITH UNREALISTIC EXPECTATIONS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method